EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family

Samira Kalayinia iD, Hamed Hesami, Reza Shervin Badv, Maryam Rabbani, Zahra Rezaei iD, Zohreh Hosseinkhani, Sedighe Nikbakht, Ameneh Sharifi, Bahman Akbari, Siamak Mirab Samiee, Nejat Mahdieh iD

Molecular Genetics & Genomic Medicine · 2025

DOI: 10.1002/mgg3.70081 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Samira Kalayinia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran. Hauptthemen laut MEDLINE: Intellectual Disability, Cerebellar Ataxia, Adenosine Triphosphatases. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebellar ataxia, mental retardation, and dysequilibrium (CAMRQ) syndrome is a rare neurodevelopmental disorder characterized by non‐progressive cerebellar ataxia, intellectual disability, and cerebellar atrophy. Despite its rarity, CAMRQ syndrome poses significant challenges due to its heterogeneous genetic etiology and complex clinical presentation. This study details the evolving clinical phenotype over 7 years in a male with CAMRQ4 syndrome caused by an in‐frame deletion variant in ATP8A2 gene.

Methods

A detailed clinical evaluation was performed, accompanied by tests and imaging studies. Clinical and genetic investigations, including segregation analysis, were carried out to confirm the pathogenicity of the identified variant. The evolving clinical phenotype of the patient, including developmental delay, cerebellar ataxia, and hand‐foot crawling, was thoroughly investigated.

Results

A 10‐year‐old male patient with CAMRQ syndrome exhibited typical clinical manifestations including impaired motor coordination, cognitive impairment, and balance disturbances. Genetic analysis revealed a homozygous in‐frame deletion variant (c.1286_1288delAGA) in the ATP8A2 gene, implicating ATP8A2 in the pathogenesis of CAMRQ syndrome. This variant was predicted to be likely pathogenic and deleterious, in accordance with its segregation in affected family members. Our findings expand the mutational spectrum of ATP8A2‐associated CAMRQ syndrome and underscore the importance of comprehensive genetic testing in diagnosing rare neurological disorders.

Conclusion

The identification of an in‐frame deletion variant in the ATP8A2 gene enhances our understanding of CAMRQ syndrome and highlights the phenotypic variability of the disorder. Our study contributes to the elucidation of CAMRQ syndrome by identifying a novel genetic variant and elucidating its clinical and genetic implications. Further research is warranted to advance our understanding of CAMRQ syndrome and to improve patient care and management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityCerebellar AtaxiaAdenosine TriphosphatasesHumansMaleChildPedigreeIranPhenotypePhospholipid Transfer Proteins

Stichwörter der Autor:innen

ATP8A2 geneCAMRQ syndromecerebellar ataxiamental retardation

Substanzen

ATP8A2 protein, humanAdenosine TriphosphatasesPhospholipid Transfer Proteins

Autor:innen und Institutionen

  • Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
  • Rajaie Cardiovascular Institute, Tehran, Iran.
  • Children's Medical Centre, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Prosthodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pediatric Neurology Department, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Samira Kalayinia, Zahra Rezaei, Nejat Mahdieh

Zitieren

APA

Kalayinia, S., Hesami, H., Badv, R. S., Rabbani, M., Rezaei, Z., Hosseinkhani, Z., Nikbakht, S., Sharifi, A., Akbari, B., Mirab Samiee, S., & Mahdieh, N. (2025). Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70081

Vancouver

Kalayinia S, Hesami H, Badv RS, Rabbani M, Rezaei Z, Hosseinkhani Z, et al. Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70081

BibTeX
@article{Kalayinia2025,
  author = {Kalayinia, Samira and Hesami, Hamed and Badv, Reza Shervin and Rabbani, Maryam and Rezaei, Zahra and Hosseinkhani, Zohreh and Nikbakht, Sedighe and Sharifi, Ameneh and Akbari, Bahman and Mirab Samiee, Siamak and Mahdieh, Nejat},
  title = {Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  doi = {10.1002/mgg3.70081}
}
Kostenlos starten →